FOLD vs MS · rev $528.3M vs P/E 20, $344.27B cap
Amicus Therapeutics Inc (FOLD) versus Morgan Stanley (MS) — a side-by-side from cached financials, not a winner call.
Amicus Therapeutics Inc (FOLD) is a biotechnology company listed on US.
Morgan Stanley (MS) is a capital markets company listed on US. It is led by Ted Pick.
Latest reported FOLD revenue for 2024-12-31 was $528.3M. Net income was -$56.1M. Revenue was up 32.3% from 2023-12-31 to 2024-12-31. FOLD currently screens at market cap $1.80B.
MS does not have a complete income-statement cache yet.
FOLD currently screens at market cap $1.80B. MS currently screens at market cap $344.27B and trailing P/E 19.8.
Not investment advice. Open the FOLD and MS stock pages for the full models.
Not investment advice.